2018
DOI: 10.1038/s41589-018-0128-y
|View full text |Cite
|
Sign up to set email alerts
|

Post-translational site-selective protein backbone α-deuteration

Abstract: Isotopic replacement has long-proven applications in small molecules. However, applications in proteins are largely limited to biosynthetic strategies or exchangeable (for example, N-H/D) labile sites only. The development of postbiosynthetic, C-H → C-H/D replacement in proteins could enable probing of mechanisms, among other uses. Here we describe a chemical method for selective protein α-carbon deuteration (proceeding from Cys to dehydroalanine (Dha) to deutero-Cys) allowing overall H→H/D exchange at a nonex… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
26
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(28 citation statements)
references
References 57 publications
1
26
0
Order By: Relevance
“…15,16 To obviate this issue and to leverage the fact that the precursor peptide of 1 (MroA1) lacked Cys, we hypothesized that replacement of Ser1 and Ser6 residues with Cys would enable a convenient desulfurization using dibromohexanediamide (3, DBHDA). [20][21][22][23] The product of this reaction would be the putative substrate for an MroD-catalyzed [4+2]-cycloaddition ( Figure 2B). (Figure S1).…”
Section: Resultsmentioning
confidence: 99%
“…15,16 To obviate this issue and to leverage the fact that the precursor peptide of 1 (MroA1) lacked Cys, we hypothesized that replacement of Ser1 and Ser6 residues with Cys would enable a convenient desulfurization using dibromohexanediamide (3, DBHDA). [20][21][22][23] The product of this reaction would be the putative substrate for an MroD-catalyzed [4+2]-cycloaddition ( Figure 2B). (Figure S1).…”
Section: Resultsmentioning
confidence: 99%
“…46,47 Similar to the often-targeted chemistry that links peptidoglycan in the bacterial cell wall, FlgE Lal formation, also in the periplasm, has no known parallel in mammals and thus, crosslinking inhibitors are well positioned to avoid cross-reactivity with host metabolism. 48 Finally, DHA is increasingly being used for protein engineering and proteomic studies; 39,40,49,50 therefore the understanding of its formation and reactivity in the context of FlgE may advance its utility for such applications.…”
Section: Discussionmentioning
confidence: 99%
“…3a, top inset). The DHA intermediate is fleeting in the course of normal Lal crosslinking; thus, to produce the intermediate in high yield, WT Td FlgE D2 was treated with the cysteine alkylating agent 2,5-dibromohexanediamide (DBA) 39,40 and DHA formation was confirmed by LC-MS ( Supplementary Fig. 7a).…”
Section: Structural Characterization Of Wt Dha and Lal Crosslinked mentioning
confidence: 99%
“…Posttranslational mutagenesis displays excellent site selectivity and regioselectivity (>98% β γ), time efficiency, compatible with a board spectrum of macromolecules (all α, α/β folds, all β, receptor, enzyme, antibody) and untouching biological functional groups 199,207,208 . Now, these methods have been used in a chemical biology way to understand the biological functions of PTM isoforms 209 through direct protein‐engineering 210 . A widely used case is the installation of fluorescent dyes on proteins, allowing the measurements of physiological parameters with optical techniques 184 .…”
Section: Targeting Ptm Protein Isoforms In Drug Designmentioning
confidence: 99%